Monopar Therapeutics (MNPR) Insider Trading

Sector: Biotechnology · Market Cap: $629M · 0 insider purchases in the last 7 days

No open market insider purchases at Monopar Therapeutics in the last 7 days.

Want more?

Sign up free to see 30+ days of history, set alerts, and track MNPR on your watchlist.

Start for Free

About Monopar Therapeutics Insider Trading

There have been no open market insider purchases at Monopar Therapeutics (MNPR) in the past 90 days.

MNPR is in the Biotechnology sector.

The company has a market cap of $629M.

Create a free Insider Trading Tracker account to get email alerts the moment an insider buys MNPR stock.

More Insider Trading in Biotechnology

PALI

PALISADE BIO, INC.

4 purchases (7d)

BCDA

BioCardia, Inc.

29 purchases (7d)

PRQR

ProQR Therapeutics N.V.

1 purchases (7d)

SER

Serina Therapeutics, Inc.

6 purchases (7d)

LRMR

Larimar Therapeutics, Inc.

11 purchases (7d)

SHPH

Shuttle Pharmaceuticals Holdings, Inc.

1 purchases (7d)

Related Screeners

Largest Insider Buys

The biggest open-market insider purchases across the market in the last 30 days.

Top Cluster Buys

Companies where 3+ different insiders bought stock in the last 30 days.